Susan Franks
General Counsel bij ELIEM THERAPEUTICS, INC.
Profiel
Currently, Susan Franks holds the position of Senior Vice President & Head-Regulatory Affairs at Eliem Therapeutics, Inc.
Ms. Franks previously was Senior Vice President & Head-Regulatory Affairs at Braeburn, Inc. and Vice President- Global Regulatory Affairs at Teva Pharmaceuticals USA, Inc.
Ms. Franks received an undergraduate degree from Clarkson University and a graduate degree from Lehigh University.
Actieve functies van Susan Franks
Bedrijven | Functie | Begin |
---|---|---|
ELIEM THERAPEUTICS, INC. | General Counsel | 05-04-2022 |
Eerdere bekende functies van Susan Franks
Bedrijven | Functie | Einde |
---|---|---|
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | General Counsel | - |
BRAEBURN INC. | General Counsel | - |
Opleiding van Susan Franks
Clarkson University | Undergraduate Degree |
Lehigh University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ELIEM THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Health Technology |
Braeburn, Inc.
Braeburn, Inc. Miscellaneous Commercial ServicesCommercial Services Braeburn, Inc. manufactures pharmaceutical products. It focuses on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain and schizophrenia. The firm develops Probuphine for the treatment of adult patients with opioid dependence. The company was founded in 2012 and is headquartered in Princeton, NJ. | Commercial Services |